1) A Children's Oncology Group Phase I Study of Bevacizumab in Refractory
Solid Tumors. This study is being conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu73002.html
2) A Children's Oncology Group Phase I Study of Single Agent OSI-774
 (Tarceva) Followed by OSI-774 with Temozolomide for Patients with Selected
 Recurrent/Refractory Solid Tumors, Including Brain Tumors. This study is
 being conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu73003.html
3) A Phase I Study of 17-AAG in Relapsed / Refractory Pediatric Patients
 with Solid Tumors or Leukemia. This study is being conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu73000.html
4) A Phase I Study of Pemetrexed (LY231514, Alimta) in Children and
 Adolescents with Recurrent Solid Tumors. This study is being conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu73005.html
5) A Phase I Trial of G3139 (BCL-2 ANTISENSE) Combined with Cytotoxic
 Chemotherapy in Relapsed Childhood Solid Tumors. This study is being
 conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu72996.html
6) A Phase I Study of Decitabine in Combination with Doxorubicin and
 Cyclophosphamide in the Treatment of Relapsed or Refractory Solid Tumors.
 This study is being conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu72999.html
7) A Phase I Study of Depsipeptide in Pediatric Patients with Refractory
 Solid Tumors and Leukemias. This study is being conducted in:
    - Cincinnati, OH
 http://www.centerwatch.com/patient/studies/stu72997.html
Additional educational resource that may be of interest to you:
Volunteering for a Clinical Trial, a brief educational pamphlet. If you
 would like to order this pamphlet click here:
 http://www.centerwatch.com/bookstore/pubs_cons_brochureform.html